---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-106818"
form_type: "8-K"
ticker: "KYNB"
cik: "0000921299"
company_name: "KYNTRA BIO, INC."
filed_at: "2024-09-16T23:59:59+00:00"
generated_at: "2026-05-31T04:49:49.505532+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# FibroGen receives Nasdaq delisting notice over bid price below $1.00

## Summary
- Nasdaq notified FibroGen on Sept 12 that its stock closed below $1.00 for 30 consecutive days, triggering potential delisting.
- FibroGen has 180 days, until March 11, 2025, to regain compliance by achieving a closing bid of at least $1.00 for ten consecutive business days.
- If not compliant by March 11, FibroGen may seek an additional 180-day period if it meets other listing requirements and intends to cure, e.g., via reverse stock split.
- FibroGen currently meets all other Nasdaq continued listing standards except the bid price requirement.

## SEC filing metadata
- accession: 0000950170-24-106818
- form_type: 8-K
- ticker: KYNB
- cik: 0000921299
- company_name: KYNTRA BIO, INC.
- filed_at: 2024-09-16T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921299/000095017024106818/0000950170-24-106818-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921299/000095017024106818/fgen-20240912.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-106818
- JSON: https://secwatch.observer/filing/0000950170-24-106818.json
- Plain text: https://secwatch.observer/filing/0000950170-24-106818.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.